There's a new drug to prevent Covid-19, but there won't be nearly enough for Americans who are eligible
CNN
For Americans who suffer from weak immune systems, it felt like a miracle occurred on December 8. That day, the US Food and Drug Administration authorized a drug to help keep immune-compromised people from getting infected with the coronavirus.
But that joy quickly turned to despair as patients learned the government has only contracted for enough doses for less than one-tenth the number of people who are eligible for it.
The first batch of the drug, called Evusheld, shipped out on Monday, according to a spokesperson for the US Department of Health and Human Services. Dr. Camille Kotton, an infectious disease expert at Mass General Brigham, said her medical system expects to receive in this shipment only doses to treat fewer than 1% of its thousands of immune-compromised patients.
5 things to know for May 30: Presidential race, Flag controversy, Gaza, Volcano eruption, Price cuts
CNN’s 5 Things brings you the news you need to know every morning.